USANA Health Sciences, Inc. (NYSE:USNA) Short Interest Up 2,787.0% in July

USANA Health Sciences, Inc. (NYSE:USNA) was the target of a large growth in short interest in July. As of July 15th, there was short interest totaling 796,800 shares, agrowthof2,787.0% from the June 30th total of 27,600 shares. Based on an average trading volume of 174,100 shares, the short-interest ratio is currently 4.6 days. Approximately7.2% of the company’s stock are short sold. Approximately7.2% of the company’s stock are short sold. Based on an average trading volume of 174,100 shares, the short-interest ratio is currently 4.6 days.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,515 shares of the firm’s stock in a transaction that occurred on Wednesday, July 30th. The shares were sold at an average price of $30.26, for a total transaction of $106,363.90. Following the sale, the insider owned 9,260 shares of the company’s stock, valued at approximately $280,207.60. This trade represents a 27.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Walter Noot sold 6,291 shares of the business’s stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total transaction of $190,554.39. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,528 shares of company stock valued at $466,513. Corporate insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On USANA Health Sciences

A number of institutional investors have recently modified their holdings of the business. Pzena Investment Management LLC raised its stake in shares of USANA Health Sciences by 9.4% during the second quarter. Pzena Investment Management LLC now owns 1,198,260 shares of the company’s stock worth $36,583,000 after purchasing an additional 103,074 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its stake in USANA Health Sciences by 46.2% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 188,511 shares of the company’s stock valued at $5,084,000 after buying an additional 59,535 shares during the period. Dimensional Fund Advisors LP raised its position in USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock worth $27,751,000 after buying an additional 55,059 shares during the last quarter. Nuveen LLC purchased a new position in USANA Health Sciences during the 1st quarter worth $895,000. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of USANA Health Sciences by 23.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 173,997 shares of the company’s stock worth $4,693,000 after acquiring an additional 33,141 shares during the period. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Stock Performance

USANA Health Sciences stock opened at $28.85 on Friday. USANA Health Sciences has a fifty-two week low of $23.10 and a fifty-two week high of $43.26. The company has a market capitalization of $537.19 million, a P/E ratio of 16.03, a PEG ratio of 0.93 and a beta of 0.61. The stock has a 50-day simple moving average of $30.90 and a 200-day simple moving average of $29.94.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.54 by $0.20. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. The company had revenue of $235.85 million for the quarter, compared to analyst estimates of $225.20 million. As a group, analysts forecast that USANA Health Sciences will post 2.45 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research report on Thursday, May 22nd.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.